What can be learned in the snake antivenom field from the developments in human plasma derived products?

@article{Burnouf2018WhatCB,
  title={What can be learned in the snake antivenom field from the developments in human plasma derived products?},
  author={Thierry Burnouf},
  journal={Toxicon : official journal of the International Society on Toxinology},
  year={2018},
  volume={146},
  pages={
          77-86
        }
}
Human plasma-derived medicinal products and snake antivenom immunoglobulins are unique and complex therapeutic protein products. Human plasma products are obtained by fractionating large pools of plasma collected from blood plasma donors. They comprise a wide range of protein products, including polyvalent and hyperimmune immunoglobulins, coagulation factors, albumin, and various protease inhibitors that are transfused to patients affected by congenital or acquired protein deficiencies… CONTINUE READING
2
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 82 REFERENCES

Adverse effects of human immunoglobulin therapy.

  • Transfusion medicine reviews
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Modern plasma fractionation.

  • Transfusion medicine reviews
  • 2007
VIEW 9 EXCERPTS

Three generations of immunoglobulin G preparations for clinical use.

  • Reviews of infectious diseases
  • 1986
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Cryoprecipitate quality and supply.

  • Transfusion
  • 1975
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Quantifying the thrombogenic potential of human plasma-derived immunoglobulin products.

  • Biologicals : journal of the International Association of Biological Standardization
  • 2014
VIEW 4 EXCERPTS

Antivenoms for the treatment of snakebite envenomings: the road ahead.

  • Biologicals : journal of the International Association of Biological Standardization
  • 2011
VIEW 6 EXCERPTS